文献速递乳腺癌

全球乳腺癌诊断时分期分布:系统综述与荟萃分析

Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis.
PubMed 文献 · JAMA Oncol · 2024-01-01

全球远处转移性乳腺癌比例在撒哈拉以南非洲为5.6%至30.6%,北美为0.0%至6.0%;过去20年远处转移比例从约3.8%至35.8%(2000年代初)降至3.2%至11.6%(2015年起),但部分出现稳定或轻微上升。高龄和较低社会经济地位人群远处转移比例更高。

要点

  • 诊断时远处转移比例从约3.8%至35.8%(2000年代初)降至3.2%至11.6%(2015年起),但部分出现稳定或轻微上升。
  • 高龄和较低社会经济地位人群诊断时远处转移比例更高,不平等持续存在。

核心结论

  • 高收入国家有效政策和干预使诊断时转移性乳腺癌比例下降,但不平等持续存在,需通过提高乳腺癌症状意识和早期检测加以解决。
  • 改善基于人群癌症登记处的全球覆盖和质量,包括收集标准化分期数据,是监测进展的关键。

研究设计与样本

  • 系统综述与荟萃分析,系统检索MEDLINE和Web of Science数据库、登记处网站及灰色文献,检索2000年1月1日至2022年6月20日发表的文献或报告。
  • 纳入基于人群癌症登记处的原发性乳腺癌(C50)诊断时分期报告,由2对评审者独立提取研究特征和结果,评估癌症登记数据质量和偏倚风险。

主要发现

  • 全球诊断时远处转移性乳腺癌比例在撒哈拉以南非洲高,范围为5.6%至30.6%,在北美低,范围为0.0%至6.0%。
  • 诊断时远处转移比例从约3.8%至35.8%(2000年代初)降至3.2%至11.6%(2015年起),但也观察到稳定或轻微上升。
  • 高龄和较低社会经济地位人群诊断时远处转移分期比例最大,从较年轻组的2.0%至15.7%升至最年长组的4.1%至33.9%,从最不弱势组的1.7%至8.3%升至最弱势组的2.8%至11.4%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Stage at diagnosis is a key prognostic factor for cancer survival. OBJECTIVE: To assess the global distribution of breast cancer stage by country, age group, calendar period, and socioeconomic status using population-based data. DATA SOURCES: A systematic search of MEDLINE and Web of Science databases and registry websites and gray literature was conducted for articles or reports published between January 1, 2000, and June 20, 2022. STUDY SELECTION: Reports on stage at diagnosis for individuals with primary breast cancer (C50) from a population-based cancer registry were included. DATA EXTRACTION AND SYNTHESIS: Study characteristics and results of eligible studies were independently extracted by 2 pairs of reviewers (J.D.B.F., A.D.A., A.M., R.S., and F.G.). Stage-specific proportions were extracted and cancer registry data quality and risk of bias were assessed. National pooled estimates were calculated for subnational or annual data sets using a hierarchical rule of the most relevant and high-quality data to avoid duplicates. MAIN OUTCOMES AND MEASURES: The proportion of women with breast cancer by (TNM Classification of Malignant Tumors or the Surveillance, Epidemiology, and End Results Program [SEER]) stage group. RESULTS: Data were available for 2.4 million women with breast cancer from 81 countries. Globally, the proportion of cases with distant metastatic breast cancer at diagnosis was high in sub-Saharan Africa, ranging from 5.6% to 30.6% and low in North America ranging from 0.0% to 6.0%. The proportion of patients diagnosed with distant metastatic disease decreased over the past 2 decades from around 3.8% to 35.8% (early 2000s) to 3.2% to 11.6% (2015 onwards), yet stabilization or slight increases were also observed. Older age and lower socioeconomic status had the largest proportion of cases diagnosed with distant metastatic stage ranging from 2.0% to 15.7% among the younger to 4.1% to 33.9% among the oldest age group, and from 1.7% to 8.3% in the least disadvantaged groups to 2.8% to 11.4% in the most disadvantaged groups. CONCLUSIONS AND RELEVANCE: Effective policy and interventions have resulted in decreased proportions of women diagnosed with metastatic breast cancer at diagnosis in high-income countries, yet inequality persists, which needs to be addressed through increased awareness of breast cancer symptoms and early detection. Improving global coverage and quality of population-based cancer registries, including the collection of standardized stage data, is key to monitoring progress.

来源:JAMA Oncol,查看原文。版权归原作者所有。

引用

  1. Benitez Fuentes JD, Morgan E, de Luna Aguilar A, et al. Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis. JAMA Oncol. 2024. PMID: 37943547. doi:10.1001/jamaoncol.2023.4837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。